Europe’s Genomic Revolution: NGS Market Set to Surge by 2034
Europe’s healthcare and life sciences ecosystem is undergoing a profound transformation, driven by the rapid expansion of Next-Generation Sequencing (NGS). Once considered a niche research tool, NGS has now evolved into a cornerstone of modern medicine, enabling breakthroughs in disease diagnosis, drug discovery, and personalized healthcare. As technological advancements accelerate...
0 Comments 0 Shares 583 Views 0 Reviews